Astellas Pharma, Inc.

- OTCPK - Current
What's your position on ?
Why are you ish?
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Fri, Jan. 22, 9:37 AM
    | Fri, Jan. 22, 9:37 AM | 10 Comments
  • Nov. 10, 2015, 6:57 AM
    • Astellas Pharma (OTCPK:ALPMF)(OTCPK:ALPMY) acquires Ocata Therapeutics (NASDAQ:OCAT) for $8.50 per share in cash or ~$379M. The tender offer will commence no late than November 25 and will not extend beyond May 9, 2016. The transaction will enable Astellas to establish a presence in ophthalmology and a leading position in cell therapy.
    • The deal is not expected to impact Astellas' fiscal year (ended March 31) financials to a significant degree.
    • OCAT closed yesterday at $4.46.
    | Nov. 10, 2015, 6:57 AM | 74 Comments
Company Description
Currently, there's no company description for ALPMF.
Sector: Healthcare
Country: Japan